Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Leandro Michelon, Ivanor Meira-Lima, Quirino Cordeiro, Karen Miguita, Gerome Breen, David Collier, Homero Vallad. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neuroscience letters. vol 403. issue 3. 2006-09-01. PMID:16787706. |
in the present study we investigated the influence of a series variants in genes (the serotonin transporter, glycogen synthase kinase-3beta, inositol polyphosphatase 1-phosphate, brain-derived neurotrophic factor and activator protein 2beta) related to the action of lithium carbonate, a drug used for prophylaxis in mood disorders. |
2006-09-01 |
2023-08-12 |
Not clear |
A Payto. Investigating cognitive genetics and its implications for the treatment of cognitive deficit. Genes, brain, and behavior. vol 5 Suppl 1. 2006-05-04. PMID:16417617. |
over the past 6 years, a number of quantitative trait loci (qtls) have been associated with cognitive functioning in humans including loci within the genes catechol-o-methyltransferase, brain-derived neurotrophic factor, muscle segment homeobox 1, serotonin transporter 2a (htr2a), cholinergic muscarinic receptor 2, cathepsin d, metabotrophic glutamate receptor and most recently the class ii human leukocyte antigens. |
2006-05-04 |
2023-08-12 |
human |
John R Grider, Barbara E Piland, Melisa A Gulick, Li Ya Qia. Brain-derived neurotrophic factor augments peristalsis by augmenting 5-HT and calcitonin gene-related peptide release. Gastroenterology. vol 130. issue 3. 2006-04-06. PMID:16530518. |
brain-derived neurotrophic factor augments peristalsis by augmenting 5-ht and calcitonin gene-related peptide release. |
2006-04-06 |
2023-08-12 |
Not clear |
Renee F Ren-Patterson, Lauren W Cochran, Andrew Holmes, Suzanne Sherrill, Su-Jan Huang, Teresa Tolliver, Klaus-Peter Lesch, Bai Lu, Dennis L Murph. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. Journal of neuroscience research. vol 79. issue 6. 2005-07-15. PMID:15672416. |
loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. |
2005-07-15 |
2023-08-12 |
mouse |
Julieta Alfonso, Alberto C Frasch, Gabriele Flugg. Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus. Reviews in the neurosciences. vol 16. issue 1. 2005-06-23. PMID:15810653. |
modifications in the expression level of some genes, such as brain-derived neurotrophic factor, camp-response-element binding protein, serotonin receptors and hpa axis components were consistently associated in a number of experimental models. |
2005-06-23 |
2023-08-12 |
Not clear |
Matthew E Szapacs, Tiffany A Mathews, Lino Tessarollo, W Ernest Lyons, Laura A Mamounas, Anne M Andrew. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. Journal of neuroscience methods. vol 140. issue 1-2. 2005-04-12. PMID:15589338. |
exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of bdnf protein and extraneuronal 5-ht in mice with reduced serotonin transporter or bdnf expression. |
2005-04-12 |
2023-08-12 |
mouse |
A Serretti, P Artiol. The pharmacogenomics of selective serotonin reuptake inhibitors. The pharmacogenomics journal. vol 4. issue 4. 2005-03-07. PMID:15111987. |
several genetic polymorphisms have been associated with therapeutic ssri response, including genetic variants of the 5-ht transporter, 5-ht-2a-receptor, tryptophan hydroxylase, brain-derived neurotrophic factor, g-protein beta3 subunit, interleukin-1beta and angiotensin-converting enzyme, although with conflicting results; also cytochrome p450 drug-metabolising enzymes may bear a particular importance, although further corroboration of the findings is necessary, and further key participating genes remain to be identified. |
2005-03-07 |
2023-08-12 |
Not clear |
Jacob Pade Ramsøe Jacobsen, Arne Mør. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain research. vol 1024. issue 1-2. 2005-01-06. PMID:15451381. |
the effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mrna and protein expression in the rat brain and the correlation to 5-ht and 5-hiaa levels. |
2005-01-06 |
2023-08-12 |
rat |
Mark J Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Trevor Sharp, Jean-Louis Peglion, Anne Dekeyn. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. The Journal of pharmacology and experimental therapeutics. vol 309. issue 3. 2004-07-01. PMID:14978196. |
finally, chronic administration of s32504 did not, in contrast to venlafaxine, modify corticolimbic levels of serotonin(2a) receptors or brain-derived neurotrophic factor. |
2004-07-01 |
2023-08-12 |
mouse |
James B Koprich, Nicholas G Campbell, Jack W Lipto. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. Brain research. Developmental brain research. vol 147. issue 1-2. 2004-05-03. PMID:14741762. |
neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. |
2004-05-03 |
2023-08-12 |
rat |
Robert H Lipsky, David Goldma. Genomics and variation of ionotropic glutamate receptors. Annals of the New York Academy of Sciences. vol 1003. 2004-02-13. PMID:14684433. |
however, functional variants of (1) catechol-o-methyltransferase, (2) serotonin transporter, and (3) brain-derived neurotrophic factor have recently been linked both to behavioral differences and to intermediate phenotypes, suggesting a pathway by which functional variation at igrs can be tied to an etiologically complex phenotype. |
2004-02-13 |
2023-08-12 |
mouse |
Cynthia L Bethea, Nicholas Z Lu, Arubala Reddy, Terry Shlaes, John M Streicher, Scott R Whittemor. Characterization of reproductive steroid receptors and response to estrogen in a rat serotonergic cell line. Journal of neuroscience methods. vol 127. issue 1. 2003-09-30. PMID:12865146. |
immunohistochemistry with a panel of antibodies, rt-pcr and a serotonin elisa were utilized to characterize the rn46a-v1 cells (herein called rn46a), and the subclone rn46a-b14 (herein called b14) that is stably transfected with brain derived neurotrophic factor (bdnf). |
2003-09-30 |
2023-08-12 |
rat |
B C Hains, K M Johnson, M J Eaton, W D Willis, C E Hulsebosc. Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience. vol 116. issue 4. 2003-04-30. PMID:12617951. |
presuming that this hyperexcitability can be explained in part by interruption of descending inhibitory modulation by serotonin, we hypothesized that intrathecal transplantation of rn46a-b14 serotonergic precursor cells, which secrete serotonin and brain-derived neurotrophic factor, would reduce this hyperexcitability by normalizing the responses of low-threshold mechanoreceptive, nociceptive-specific, and multireceptive dorsal horn neurons. |
2003-04-30 |
2023-08-12 |
rat |
Elizabeth A Debski, Hollis T Clin. Activity-dependent mapping in the retinotectal projection. Current opinion in neurobiology. vol 12. issue 1. 2002-04-04. PMID:11861170. |
nitric oxide and brain-derived neurotrophic factor, candidate retrograde messengers, and serotonin and acetylcholine, modulators of neuronal excitability, all affect mapping. |
2002-04-04 |
2023-08-12 |
Not clear |
D Galter, K Unsicke. Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons. Neuroscience. vol 88. issue 2. 1999-06-01. PMID:10197774. |
the ability of cells to specifically take up the serotonin analog 5,7-dihydroxytryptamine was also up-regulated by brain-derived neurotrophic factor in both rostral and caudal raphe cultures. |
1999-06-01 |
2023-08-12 |
rat |
C A Altar, M Fritsche, R M Lindsa. Cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis. Advances in pharmacology (San Diego, Calif.). vol 42. 1997-11-25. PMID:9328047. |
cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis. |
1997-11-25 |
2023-08-12 |
Not clear |
D Lindholm, J Harikka, M da Penha Berzaghi, E Castrén, G Tzimagiorgis, R A Hughes, H Thoene. Fibroblast growth factor-5 promotes differentiation of cultured rat septal cholinergic and raphe serotonergic neurons: comparison with the effects of neurotrophins. The European journal of neuroscience. vol 6. issue 2. 1994-06-02. PMID:8167846. |
the effect of fgf-5 on serotonin uptake was stronger than that evoked with either brain-derived neurotrophic factor or neurotrophin-3. |
1994-06-02 |
2023-08-12 |
mouse |
M T Martin-Iverson, K G Todd, C A Alta. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 14. issue 3 Pt 1. 1994-04-07. PMID:8074747. |
brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. |
1994-04-07 |
2023-08-12 |
rat |